#BEGIN_DRUGCARD DB01899

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H11N3O5P

# Chemical_IUPAC_Name:
5-[(2S)-2-amino-2-carboxyethyl]-1-phosphono-1H-imidazol-3-ium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Nd1-Phosphonohistidine

# HET_ID:
HIP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H10N3O5P/c7-5(6(10)11)1-4-2-8-3-9(4)15(12,13)14/h2-3,5H,1,7H2,(H,10,11)(H2,12,13,14)/p+1/t5-/m0/s1

# InChI_Key:
InChIKey=VOHVXLVXSYAFOA-YFKPBYRVSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1899

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
236.1424

# Molecular_Weight_Mono:
236.043631989

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JEM

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.7

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
1.79e+00 g/l

# Primary_Accession_No:
DB01899

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754026

# PubChem_Substance_ID:
46505908

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01752

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CC1=C[NH+]=CN1P(O)(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X12832

# Drug_Target_1_GenBank_ID_Protein:
580913

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ptsH

# Drug_Target_1_Gene_Sequence:
>267 bp
ATGGCACAAAAAACATTTAAAGTAACTGCAGATTCTGGAATCCATGCTCGTCCTGCGACA
GTTCTTGTACAAACTGCTAGCAAATACGACGCTGACGTTAATTTAGAATATAACGGCAAA
ACAGTTAACCTTAAATCTATTATGGGTGTTATGTCTTTAGGTATCGCTAAAGGCGCTGAG
ATCACAATCTCTGCTTCCGGAGCTGACGAAAACGATGCTCTTAACGCTTTAGAAGAAACA
ATGAAAAGCGAAGGACTCGGCGAGTAA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
12359875	Fieulaine S, Morera S, Poncet S, Mijakovic I, Galinier A, Janin J, Deutscher J, Nessler S: X-ray structure of a bifunctional protein kinase in complex with its protein substrate HPr. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13437-41. Epub 2002 Oct 1.
1303754	Wittekind M, Rajagopal P, Branchini BR, Reizer J, Saier MH Jr, Klevit RE: Solution structure of the phosphocarrier protein HPr from Bacillus subtilis by two-dimensional NMR spectroscopy. Protein Sci. 1992 Oct;1(10):1363-76.
1495386	Mitchell C, Morris PW, Vary JC: Amino acid sequences of several Bacillus subtilis proteins modified by apparent guanylylation. Mol Microbiol. 1992 Jun;6(12):1579-81.
1549615	Herzberg O, Reddy P, Sutrina S, Saier MH Jr, Reizer J, Kapadia G: Structure of the histidine-containing phosphocarrier protein HPr from Bacillus subtilis at 2.0-A resolution. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2499-503.
2119803	Wittekind M, Reizer J, Klevit RE: Sequence-specific 1H NMR resonance assignments of Bacillus subtilis HPr: use of spectra obtained from mutants to resolve spectral overlap. Biochemistry. 1990 Aug 7;29(31):7191-200.
2497294	Gonzy-Treboul G, Zagorec M, Rain-Guion MC, Steinmetz M: Phosphoenolpyruvate:sugar phosphotransferase system of Bacillus subtilis: nucleotide sequence of ptsX, ptsH and the 5'-end of ptsI and evidence for a ptsHI operon. Mol Microbiol. 1989 Jan;3(1):103-12.
7704530	Liao DI, Herzberg O: Refined structures of the active Ser83-->Cys and impaired Ser46-->Asp histidine-containing phosphocarrier proteins. Structure. 1994 Dec 15;2(12):1203-16.
8195089	Deutscher J, Reizer J, Fischer C, Galinier A, Saier MH Jr, Steinmetz M: Loss of protein kinase-catalyzed phosphorylation of HPr, a phosphocarrier protein of the phosphotransferase system, by mutation of the ptsH gene confers catabolite repression resistance to several catabolic genes of Bacillus subtilis. J Bacteriol. 1994 Jun;176(11):3336-44.
8596444	Fujita Y, Miwa Y, Galinier A, Deutscher J: Specific recognition of the Bacillus subtilis gnt cis-acting catabolite-responsive element by a protein complex formed between CcpA and seryl-phosphorylated HPr. Mol Microbiol. 1995 Sep;17(5):953-60.
8755892	Graumann P, Schroder K, Schmid R, Marahiel MA: Cold shock stress-induced proteins in Bacillus subtilis. J Bacteriol. 1996 Aug;178(15):4611-9.
9336834	Jones BE, Rajagopal P, Klevit RE: Phosphorylation on histidine is accompanied by localized structural changes in the phosphocarrier protein, HPr from Bacillus subtilis. Protein Sci. 1997 Oct;6(10):2107-19.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2514

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
9189

# Drug_Target_1_Name:
Phosphocarrier protein HPr

# Drug_Target_1_Number_of_Residues:
88

# Drug_Target_1_PDB_ID:
1SPH

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00381	PTS-HPr

# Drug_Target_1_Protein_Sequence:
>Phosphocarrier protein HPr
MAQKTFKVTADSGIHARPATVLVQTASKYDADVNLEYNGKTVNLKSIMGVMSLGIAKGAE
ITISASGADENDALNALEETMKSEGLGE

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
P-Ser-HPr interacts with the catabolite control protein A (ccpA), forming a complex that binds to DNA at the catabolite response elements cre, operator sites preceding a large number of catabolite-regulated genes. Thus, P-Ser-HPr is a corepressor in carbon catabolite repression (CCR), a mechanism that allows bacteria to coordinate and optimize the utilization of available carbon sources. P-Ser-HPr also plays a role in inducer exclusion, in which it probably interacts with several non-PTS permeases and inhibits their transport activity

# Drug_Target_1_SwissProt_ID:
P08877

# Drug_Target_1_SwissProt_Name:
PTHP_BACSU

# Drug_Target_1_Synonyms:
Histidine-containing protein

# Drug_Target_1_Theoretical_pI:
4.52

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01899
